bims-hypusi Biomed News
on Hypusine and eIF5A
Issue of 2025–07–27
one paper selected by
Sebastian J. Hofer, Max Delbrück Center



  1. Biochim Biophys Acta Mol Basis Dis. 2025 Jul 22. pii: S0925-4439(25)00339-4. [Epub ahead of print] 167991
      Eukaryotic Translation Initiation Factor 5A (eIF5A) undergoes a unique post-translational modification of hypusination, converting a lysine 50 residue to hypusine (hypK50). While a few studies have investigated the role of the spermidine-hypusine-eIF5A axis in neurodegenerative diseases, including the pathological accumulation of tau and TAR DNA-binding protein 43 (TDP-43), the role of the hypusine pathway in neurological diseases remains vastly understudied. Thus, the focus of this review is highlighting emerging research on the mechanisms by which aberrant and chronic increases in hypusinated eIF5A (eIF5AhypK50) govern nucleocytoplasmic transport, stress granule dynamics, and protein aggregation to encourage further research of this pathway in multi-etiology dementia.
    Keywords:  Hypusination; Neurodegeneration; Proteinopathy; TDP-43; eIF5A
    DOI:  https://doi.org/10.1016/j.bbadis.2025.167991